abstract |
The subject of this invention is the detection, quantitation of ras p21 proteins in body fluids, tissues, or cells. Specifically, this invention concerns detecting and quantitating normal and mutated ras p21s from normal subjects, subjects suspected of having preneoplastic disease or subjects known or suspected of having neo-plastic (cancer) disease. This invention also concerns the detection and quantitation of the ras p21 proteins into the three families of ras proteins designated Ha, Ki and N in body fluids and tissues. <IMAGE> |